Onconetix (ONCO) Notes Payables (2022 - 2026)
Onconetix (ONCO) posted quarterly Notes Payables of $956979.0 for Q1 2026, down 89.32% year-over-year from $9.0 million in Q1 2025, and down 86.3% quarter-over-quarter from $7.0 million in Q4 2025.
Onconetix (ONCO) Notes Payables (2022 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Notes Payables for 5 consecutive years, with $956979.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables fell 89.32% year-over-year to $956979.0; the TTM figure through Mar 2026 stood at $956979.0 (down 89.32% YoY), while the FY2025 annual figure was $7.0 million, down 25.11% from the prior year.
- Notes Payables eased to $956979.0 in Q1 2026 per ONCO's latest filing, from $7.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $12.9 million in Q3 2023 and bottomed at $2641.0 in Q2 2024.
- Historically, Notes Payables has averaged $5.5 million across 5 years, with a median of $7.8 million in 2023.
- Annual changes were most pronounced in 2024 — Notes Payables tumbled 99.97% — and 2025, when it soared 330516.09%.
- Onconetix's Notes Payables stood at $14021.0 in 2022, then surged by 68499.76% to $9.6 million in 2023, then decreased by 3.02% to $9.3 million in 2024, then retreated by 25.11% to $7.0 million in 2025, then tumbled by 86.3% to $956979.0 in 2026.
- Business Quant data shows ONCO's Notes Payables at $956979.0 in Q1 2026, $7.0 million in Q4 2025, and $988000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 649,134.00 |
| Mar 31, 2026 | 956,979.00 |
| Dec 31, 2025 | 6.99 Mn |
| Sep 30, 2025 | 988,000.00 |
| Jun 30, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.96 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 2,641.00 |
| Mar 31, 2024 | 10.41 Mn |
| Dec 31, 2023 | 9.62 Mn |
| Sep 30, 2023 | 12.92 Mn |
| Jun 30, 2023 | 8.62 Mn |
| Mar 31, 2023 | 12,406.00 |
| Dec 31, 2022 | 14,021.00 |
| Sep 30, 2022 | 42,056.00 |
| Jun 30, 2022 | 5,373.00 |